TABLE 6.

Direct comparisons between different drugs in the rate of serious adverse events within 30 days (reported as point estimates of odds ratios or weighted mean differences with 95% credible intervals, with number of studies contributing to network). Among them, those marked as yellow are vasodilators, those marked as green are vasoconstrictors, and those marked as white are placebos.

Conivaptan
0.62 (0.07,4.57)	KW-3902
0.93 (0.21,4.12)	1.56 (0.38,6.74)	Placebo
0.93 (0.14,7.69)	1.63 (0.24,12.60)	1.08 (0.27,4.38)	Relaxin
0.47 (0.01,6.22)	0.78 (0.02,9.82)	0.52 (0.02,4.24)	0.46 (0.01,5.94)	RhANP
1.27 (0.16,8.34)	2.21 (0.30,14.34)	1.39 (0.34,4.90)	1.26 (0.16,8.47)	2.53 (0.20,85.77)	Rolofylline
3.01 (0.28,33.06)	5.32 (0.52,53.45)	3.31 (0.52,20.60)	3.03 (0.29,27.69)	6.17 (0.37,266.00)	2.55 (0.25,25.30)	Serelaxin